Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

被引：0

作者：

Bussel, James ^{[1
]}

Tarantino, Michael ^{[1
]}

Blanchette, Victor ^{[1
]}

Raj, Ashok ^{[1
]}

Despotovic, Jenny ^{[1
]}

Beam, Donald ^{[1
]}

Roy, John ^{[1
]}

Wang, Xuena ^{[1
]}

Mehta, Bhakti ^{[1
]}

Eisen, Melissa ^{[1
]}

机构：

[1] Amgen Inc, Thousand Oaks, CA 91320 USA

来源：

PEDIATRIC BLOOD & CANCER | 2017年 / 64卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

005

引用

页码：S9 / S9

页数：1

共 50 条

[1] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
Tarantino, M.
Bussel, J.
Blanchette, V.
Despotovic, J.
Bennett, C.
Raj, A.
Williams, B.
Beam, D.
Morales, J.
Rose, M.
Wang, X.
Eisen, M.
HAEMATOLOGICA, 2016, 101 : 587 - 587
[2] Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
Bussel, James B.
Tarantino, Michael D.
Blanchette, Victor S.
Raj, Ashok
Despotovic, Jenny
Beam, Donald
Roy, John
Wang, Xuena
Mehta, Bhakti
Eisen, Melissa
BLOOD, 2016, 128 (22)
[3] SAFETY AND EFFICACY OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
Bussel, J.
Tarantino, M.
Blanchette, V.
Raj, A.
Despotovic, J.
Beam, D.
Roy, J.
Wang, X.
Mehta, B.
Eisen, M.
HAEMATOLOGICA, 2017, 102 : 294 - 294
[4] Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
Tarantino, Michael
Bussel, James B.
Blanchette, Victor S.
Beam, Donald
Roy, John
Despotovic, Jenny M.
Raj, Ashok
Carpenter, Nancy
Mehta, Bhakti
Eisen, Melissa
BLOOD, 2017, 130
[5] FINAL SAFETY AND EFFICACY DATA OF LONG-TERM OPEN-LABEL DOSING OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
Tarantino, Michael
Bussel, James
Blanchette, Victor
Beam, Donald
Roy, John
Despotovic, Jenny
Raj, Ashok
Carpenter, Nancy
Mehta, Bhaki
Eisen, Melissa
PEDIATRIC BLOOD & CANCER, 2018, 65
[6] Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)
Tarantino, Michael D.
Bussel, James B.
Blanchette, Victor S.
Despotovic, Jenny M.
Bennett, Carolyn
Raj, Ashok
Williams, Bronwyn
Beam, Donald
Morales, Jaime
Rose, Melissa J.
Nie, Kun
Eisen, Melissa
BLOOD, 2015, 126 (23)
[7] A SINGLE-ARM, OPEN-LABEL, LONG-TERM EFFICACY AND SAFETY STUDY OF SUBCUTANEOUS (SC) ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA (ITP)
Grainger, John
Bussel, James
Tarantino, Michael
Cooper, Nichola
Beam, Donald
Despotovic, Jenny
Maschan, Alexey
Carpenter, Nancy
Eisen, Melissa
Park, Joseph
PEDIATRIC BLOOD & CANCER, 2018, 65
[8] A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
Grainger, John
Bussel, James B.
Cooper, Nichola
Tarantino, Michael
Blanchette, Victor
Despotovic, Jenny
Maschan, Alexey
Carpenter, Nancy
Eisen, Melissa
Mehta, Bhakti
BLOOD, 2016, 128 (22)
[9] A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)
Grainger, John D.
Bussel, James B.
Tarantino, Michael
Cooper, Nicola
Beam, Donald
Despotovic, Jenny M.
Maschan, Alexey
Carpenter, Nancy
Eisen, Melissa
Park, Joseph
BLOOD, 2017, 130
[10] Safety and Efficacy Of Long-Term Open-Label Romiplostim Dosing In Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)
Tarantino, Michael D.
Bussel, James B.
Geddis, Amy
Guerrera, Michael F.
Ikeda, Alan K.
Nie, Kun
Eisen, Melissa
BLOOD, 2013, 122 (21)

← 1 2 3 4 5 →